<unk> , sold under the brand name Xolair, is a medication used to treat asthma, nasal polyps, and urticaria.<unk>  is a recombinant DNA-derived humanized IgG1k monoclonal antibody that specifically binds to free human immunoglobulin E (IgE) in the blood and interstitial fluid and to membrane-bound form of IgE (mIgE) on the surface of mIgE-expressing B lymphocytes. Unlike an ordinary anti-IgE antibody, it does not bind to IgE that is already bound by the high affinity IgE receptor (FcεRI) on the surface of mast cells, basophils, and antigen-presenting dendritic cells.
Omalizumab
Crizanlizumab
Reslizumab
Lirentelimab
Tildrakizumab
Risankizumab
Bebtelovimab
Brolucizumab